×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
How it Works
🎨
Pitch
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
How it Works
Pitch
Showcase
Demo
←
Home
/
Wiki
/
Cell: Disease-Associated Microglia (DAM)
cell
620 words
KG: DAM
2026-03-24
kind:cell-type
section:cell-types
state:published
Contents
Disease-Associated Microglia (DAM)
🧫
Cell Type Info
Cell Type
DAM
Associated Diseases
Neurodegenerative Diseases
,
Alzheimer's Disease
,
NEURODEGENERATION
,
ALZHEIMERS
Related Genes
TREM2
,
SYK
,
AMYLOID
Linked Hypotheses
47 hypotheses
Knowledge Graph
Related Hypotheses (30)
ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro
Score: 0.66
Targeted Butyrate Supplementation for Microglial Phenotype M
Score: 0.56
Senescent Microglia Resolution via Maresins-Senolytics Combi
Score: 0.55
Microglial-Mediated Tau Clearance Dysfunction via TREM2 Sign
Score: 0.53
Cell-Type Specific TREM2 Upregulation in DAM Microglia
Score: 0.52
40 Hz Gamma Entrainment Gates ACSL4-Mediated Ferroptotic Pri
Score: 0.51
Microglial TREM2 downregulation impairs damage-associated re
Score: 0.51
Disease-Associated Microglia Metabolic Reprogramming
Score: 0.50
TREM2-APOE4 Co-targeting — Simultaneous Correction of Lipid
Score: 0.49
Microbiota-Microglia Axis Modulation
Score: 0.48
Temporal Microglial State Switching
Score: 0.46
TREM2-Mediated Microglial Checkpoint Therapy
Score: 0.46
Stage-Selective TREM2 Agonism — Boosting DAM Phagocytosis in
Score: 0.46
TREM2-DAP12 Signalosome Enhancement — Boosting PI3K-AKT-mTOR
Score: 0.45
IGFBPL1-Mediated Homeostatic Restoration
Score: 0.45
Complement C1QA Spatial Gradient in Cortical Layers
Score: 0.43
Optogenetic Microglial Deactivation via Engineered Inhibitor
Score: 0.38
TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegen
Score: 0.64
Prime Editing Precision Correction of APOE4 to APOE3 in Micr
Score: 0.62
TREM2-Mediated Astrocyte-Microglia Cross-Talk in Neurodegene
Score: 0.61
Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59
Competitive APOE4 Domain Stabilization Peptides
Score: 0.56
Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.51
TREM2-mediated microglial tau clearance enhancement
Score: 0.49
TREM2 Conformational Stabilizers for Synaptic Discrimination
Score: 0.41
TREM2-Dependent Microglial Senescence Transition
Score: 0.69
Synthetic Biology BBB Endothelial Cell Reprogramming
Score: 0.57
Senescent Cell Mitochondrial DNA Release
Score: 0.54
APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.54
Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.53
Show 25 more
Related Analyses (30)
Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · archived
Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · completed
TREM2 agonism vs antagonism in DAM microglia
neurodegeneration · failed
TREM2 agonism vs antagonism in DAM microglia
neurodegeneration · archived
Immune atlas neuroinflammation analysis in neurodegeneration
Neuroinflammation · archived
Microglial subtypes in neurodegeneration — friend vs foe
neuroscience · failed
Immune atlas neuroinflammation analysis in neurodegeneration
Neuroinflammation · completed
Neuroinflammation and microglial priming in early Alzheimer'
neurodegeneration · archived
TREM2 Therapeutic Strategy Post-INVOKE-2
neurodegeneration · archived
Mechanistic validation of SEA-AD differential expression hyp
neurodegeneration · failed
Do these mechanistic hypotheses explain layer-specific synap
neurodegeneration · failed
Do these mechanistic hypotheses from the SEA-AD Atlas bundle
neurodegeneration · failed
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived
Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived
Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived
Synaptic pruning by microglia in early AD
neurodegeneration · archived
Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived
SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas
neurodegeneration · completed
Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · completed
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived
Is disrupted sleep a cause or consequence of neurodegenerati
neurodegeneration · failed
Is disrupted sleep a cause or consequence of neurodegenerati
neurodegeneration · failed
Cell type vulnerability in Alzheimer's Disease (SEA-AD data)
neurodegeneration · failed
Cell type vulnerability in Alzheimer's Disease (SEA-AD data
neurodegeneration · archived
TREM2 Therapeutic Strategy Post-INVOKE-2
neurodegeneration · completed
GBA-Synuclein Loop Therapeutics for PD
neurodegeneration · completed
Gut-Brain Axis Therapeutics for AD
neurodegeneration · completed
Show 25 more
Related Experiments (7)
Microglial Aging and Immune Memory in Neurodegeneration — Tr
validation · proposed · Score: 0.40
AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi
clinical · proposed · Score: 0.40
AD Combination Therapy Trial: Anti-Aβ + Anti-Tau
clinical · proposed · Score: 0.40
Sex Differences in Alzheimer's Disease — mechanisms and ther
clinical · proposed · Score: 0.40
Microglial TREM2 Agonist In Vivo Efficacy
validation · proposed · Score: 0.40
TREM2 Agonist Therapy for Parkinson's Disease — Experimental
validation · proposed · Score: 0.40
TREM2 Function in Alzheimer's Disease — From Risk Variant to
validation · proposed · Score: 0.40
Show 2 more
See Also (5)
CNS Drug Delivery Methods
mechanism · KG edge: expressed_in
APOE contributes to Alzheimer's disease by regulating b
hypothesis · KG edge: interacts_with
TREM2 Protein (Triggering Receptor Expressed on Myeloid
entity · KG edge: activates
Microglia in Neurodegeneration
entity · KG edge: associated_with
Neurodegeneration
disease · KG edge: associated_with
Knowledge Graph (12 edges)
DAM
associated_with
NEURODEGENERATION
DAM
expressed_in
CNS
DAM
associated_with
ALZHEIMERS
DAM
interacts_with
APOE
DAM
associated_with
microglia
DAM
protects_against
Neurodegeneration
DAM
mediates
Amyloid-Beta Phagocytosis
DAM
involved_in
Alzheimer's Disease
DAM
associated_with
Alzheimer's Disease
DAM
involved_in
Phagocytosis